(82 days)
Not Found
No
The summary describes a physical implant and does not mention any software, algorithms, or data processing that would indicate the use of AI or ML.
Yes
The device is described as treating a medical condition (hyperpronated foot, stabilization of the subtalar joint) by blocking excessive pronation and its sequelae, which aligns with the definition of a therapeutic device.
No
The device is an implant used for treatment, not for diagnosing conditions.
No
The device description explicitly states it is a one-piece device made of titanium intended to be implanted, indicating it is a physical hardware device, not software only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device Description: The Metasurg subtalar implant is a physical implant made of titanium that is surgically placed into the foot. It is a therapeutic device designed to treat a physical condition (hyperpronated foot and subtalar joint instability).
- Intended Use: The intended use describes a surgical intervention to stabilize a joint, not a diagnostic test performed on a sample.
Therefore, the Metasurg subtalar implant falls under the category of a surgical implant or orthopedic device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Metasurg subtalar implant is indicated for use in the treatment of the hyperpronated foot and stabilization of the subtalar joint. It is designed to block forward, downward and medial displacement of the talus, thus allowing normal subtalar joint motion but blocking excessive pronation and the resulting sequela.
The Metasurg subtalar implants are intended for single use only.
Product codes
HWC
Device Description
The Metasurg Subtalar Implant is a one-piece device made of titanium intended to be implanted into the sinus tarsi of the foot. The implant is offered in 6 sizes ranging from 7mm - 12mm in diameter. The implant is used in the treatment of excessive motion of the talus relative to the calcaneus.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
sinus tarsi of the foot, subtalar joint
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
MAY 8 -2007
:
. . .
ﺮ ﻣﺴﺎﺑ
Kop44//
510(k) Summary
Date Prepared: | February 14, 2007 |
---|---|
Sponsor: | Metasurg |
16350 Park Ten Place, Suite 101 | |
Houston, TX 77084 | |
Company Contact: | Larry Weatherford |
Phone: (281) 398-5656 | |
Fax: (281) 398-5660 | |
Device Trade Name: | Metasurg Subtalar Implant |
Classification Name: | Smooth & threaded metallic bone fixation fasteners (21 CFR |
888.3040, Product Code HWC, Class II) | |
Common Name: | Subtalar Arthrorisis Implant |
Substantial Equivalence: | Documentation is provided which demonstrates the Metasurg |
Subtalar Implant to be substantially equivalent to other legally | |
marketed devices. | |
Device Description: | The Metasurg Subtalar Implant is a one-piece device made of |
titanium intended to be implanted into the sinus tarsi of the foot. | |
The implant is offered in 6 sizes ranging from 7mm - 12mm in | |
diameter. The implant is used in the treatment of excessive | |
motion of the talus relative to the calcaneus. | |
Intended Usage: | The Metasurg Subtalar Implant is indicated for use in the |
treatment of the hyperpronated foot and stabilization of the | |
subtalar joint. It is designed to block forward, downward and | |
medial displacement of the talus, thus allowing normal subtalar | |
joint motion but blocking excessive pronation and the resulting | |
sequela. | |
The Metasurg subtalar implants are intended for single use only. | |
Material: | Titanium Alloy (Ti-6AL-4V ELI) |
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three lines representing its wings. The eagle is positioned to the right of a circular border containing the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The text is arranged around the circumference of the circle.
2007 MAY 8
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Metasurg % Mr. Larry Weatherford Vice President 16350 Park Ten Place, Suite 101 Houston, Texas 77084
Re: K070441
Trade/Device Name: Metasurg Subtalar Implant Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: II Product Code: HWC Dated: February 14, 2007 Received: February 16, 2007
Dear Mr. Weatherford:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Mr. Larry Weatherford
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120 Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Sincerely, yours,
Barbara Buell
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number: Pending
Device Name: Metasurg Subtalar Implant
Indications For Use:
The Metasurg subtalar implant is indicated for use in the treatment of the hyperpronated foot and stabilization of the subtalar joint. It is designed to block forward, downward and medial displacement of the talus, thus allowing normal subtalar joint motion but blocking excessive pronation and the resulting sequela.
The Metasurg subtalar implants are intended for single use only.
Prescription Use V (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Darlaue Buem
and Neurolog
510(k) Number K070441